Regulation of Clinical Trials: The New Life Sciences Frontier is the title of a CLE seminar being offered by the DC Bar Association.
The program is scheduled for Wednesday, January 16 from 6 to 9:15 p.m. at the DC Bar Conference Center, 1250 H Street, NW, Washington, DC.
This course will provide an orientation to legal requirements, as well as practical guidance, for lawyers representing clients in the complex and highly regulated field of human clinical trials of investigational drugs and medical devices. Faculty members will discuss the framework of the current laws and regulations applicable to medical product development. Attendees will learn the steps required to initiate and conduct a clinical trial to help clients better navigate the process.
Speakers will be Catherine M. Cook, U.S. FDA; Ellen J. Flannery, Covington & Burling; Christina M. Markus, King & Spalding LLP, and Stuart Silverman, Office of Inspector General for the District of Columbia.
For information on available CLE credits and registration fees, see the Bulletin Board on The Metropolitan Corporate Counsel website at www.metro- corpcounsel.com.
For reservations, call (202) 626-3488 or visit www.dcbar.org.